Gabapentin and ketamine to treat head and neck cancer pain
Treatments studied
Part of Cancer clinical trials.
This early-phase study tests whether gabapentin and a ketamine nasal spray can help prevent or lessen short-term and long-term pain from locally advanced head and neck cancer. It may help by changing how the nervous system responds to pain during and after radiation and chemoradiation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have confirmed head and neck cancer based on biopsy results
- Your cancer is locally advanced but not spread to distant organs (not metastatic)
- You are scheduled to get radiation, or radiation plus chemotherapy (chemoradiation)
- You are age 21 or older and can understand and sign consent in English
- Your day-to-day function is fairly good (ECOG 0 to 2)
- You are not currently taking gabapentin or ketamine
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a ketamine mouth rinse to see if it can ease the pain of mouth sores caused by radiation for head and neck cancer. If you have these sores, this rinse might help you feel more comfortable during treatment.
This trial tests a new way to give radiation therapy for head and neck cancer. By using a special PET scan to guide where higher radiation doses are given, doctors hope to improve treatment while reducing side effects. It is for people whose cancer is not early-stage and who will receive standard radiation therapy.
This trial tests if taking gabapentin during chemoradiation for head and neck cancer can reduce the need for strong painkillers like opioids. It may help manage mouth pain caused by treatment.
This study tests whether a ketamine nasal spray can help reduce depression and anxiety in people with advanced cancer. It also looks at how caregivers are affected. If you are living with progressive cancer and feeling down or anxious, this treatment might offer some relief.
This trial tests if adding lidocaine and ketamine to your current pain medicines can better control severe cancer-related pain that opioids alone haven't helped.
This Phase 1/2 study tests hydroxynorketamine (a related ketamine-type medicine) to see if it can reduce chronic nerve pain in the arms or legs. You may be able to join if you have nerve pain for more than 3 months and meet safety and health check requirements.
Hear when a new Head and Neck Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.